Recombinant Human AHSG Protein, Glycoengineered Human Cell Lines (CAT#: GLJF-0622-JF240)

Product Overview	Recombinant human AHSG protein (NP_001613.2) is produced in Glycoengineered Human Cell Lines. This expression system is used for the production of glycoproteins and antibodies with human post-translational modifications.
Source	Glycoengineered Human Cell Lines
Species	Human
Tag	His-tag, FC-tag
Purity	>90%, determined by SDS-PAGE.
Endotoxin Level	Regular batch
Conjugation	None

Target	AHSG
Full Name	Alpha-2-HS-glycoprotein
Gene ID	197
Uniprot ID	P02765
Accession Number	NP_001613.2
Background	Alpha2-HS glycoprotein (AHSG), a glycoprotein present in the serum, is synthesized by hepatocytes. The AHSG molecule consists of two polypeptide chains, which are both cleaved from a proprotein encoded from a single mRNA. It is involved in several functions, such as endocytosis, brain development and the formation of bone tissue. The protein is commonly present in the cortical plate of the immature cerebral cortex and bone marrow hemopoietic matrix, and it has therefore been postulated that it participates in the development of the tissues. However, its exact significance is still obscure.
Alternate Names	Alpha-2-Z-globulin; Ba-alpha-2-glycoprotein; Fetuin-A [Cleaved into: Alpha-2-HS-glycoprotein chain A; Alpha-2-HS-glycoprotein chain B]; AHSG; FETUA; PRO2743